The In vivo mouse experiments demonstrated that IL-33 could induce the recruitment of eosinophils, CD4+ T cells, CD8+ T cells, and macrophages to HCC, significantly reducing the number of tumor nodules. The gene discussed is IL33; the disease is hepatocellular carcinoma.